SCHEMBL6992790

SCHEMBL6992790

CC(=O)OCc1c(C)c(=S)[nH]c2ccc(Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 5/20 0.45
ALDH1A1 P00352 4/20 0.42
HPGD P15428 3/20 0.42
CYP1A2 P05177 2/20 0.42
XBP1 P17861 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
HTR7 P34969 1/20 0.40
HTR2B P41595 1/20 0.40
HTR6 P50406 1/20 0.40
CSF1R P07333 1/20 0.40
TSPO P30536 1/20 0.40
ALOX5 P09917 1/20 0.40
PTGS2 P35354 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998457 0.86 ALDH1A1 (0.50) SIRT1ALDH1A1HPGDCYP1A2XBP1
SCHEMBL27459777 0.84 ADRA2A (0.53) SIRT1ALDH1A1HPGDCYP1A2XBP1
SCHEMBL27387994 0.74 ALOX15 (0.51) PTGS2
SCHEMBL6994825 0.69 ALDH1A1 (0.41) ALDH1A1HPGDCYP1A2KDM4EHSD17B10
SCHEMBL27939080 0.69 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2C19KDM4EHSD17B10
SCHEMBL11544126 0.68 ADORA3 (0.45) CSF1R
SCHEMBL25433849 0.68 ALDH1A1 (0.55) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL8296306 0.68 PRSS1 (0.55) SIRT1ALDH1A1HPGDCYP1A2XBP1
SCHEMBL12496609 0.68 ALDH1A1 (0.66) SIRT1ALDH1A1HPGDCYP1A2XBP1
SCHEMBL27366263 0.68 ALDH1A1 (0.52) SIRT1ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003724-B1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION AVENTIS PHARMA GMBH (DE) 2003-02-12 EP disclosed
US-6114349-A Substituted quinoline derivatives with antiviral action HOECHST AKTIENGESELLSCHAFT (DE) 2000-09-05 US disclosed
EP-1003724-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION Aventis Pharma Deutschland GmbH (DE) 2000-05-31 EP disclosed
WO-1997037977-A1 SUBSTITUTED QUINOLINE DERIVATIVES WITH ANTIVIRAL ACTION HOECHST AKTIENGESELLSCHAFT (DE) 1997-10-16 WO disclosed